检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]武汉亚洲心脏病医院检验中心,邮政编码武汉430022
出 处:《微循环学杂志》2007年第4期53-55,共3页Chinese Journal of Microcirculation
摘 要:目的:检测分析冠状动脉搭桥术(CABG)-体外循环(CPB)冠心病(CHD)患者的炎性和心肌损伤监测指标。方法:分别在CPB前、中、后即刻、后2h、6h、12h、24h、48h,测定炎性指标白介素-6(IL-6)、白介素-8(IL-8)、白细胞数量(WBC)及心肌损伤标志物肌红蛋白(MYO)、肌钙蛋白I(cTnI)、肌酸激酶同工酶MB质量(CK-MBmass),并对WBC和cTnI变化进行趋势分析。结果:IL-6和IL-8在CPB后逐渐上升;WBC和cTnI在CPB后开始逐渐上升,CPB后24h达到高峰,然后下降;WBC和cTnI与其它指标呈明显正相关(P<0.01);MYO在CPB后即刻和CPB后24h出现双峰。结论:行CABG-CPB患者炎症和心肌损伤指标的监测有重要临床意义。Objective: To analyze and optimize the monitoring items of inflammatory reaction and myocardial damage for the patients with coronary heart disease (CHD), who will be undergone coronary artery by pass graft (CABG) surgery by cardiopulmonary bypass (CPB). Method: Interleukin-6 (IL-6), interleukin-8 (IL-8), white blood cell (WBC), myoglobulin (MYO), troponin I (cTnI), creatine kinase MB mass (CK-MB mass) were tested in different time spots which in order are before CPB, on CPB, after CPB at that time, after CPB 2 hour, after CPB 6 hour, after CPB 12 hour, after CPB 24 hour, after CPB 48 hour. Then analyze the changing tendencies of the preferential monitoring items WBC and cTnI. Results: The values of IL-6 and IL-8 ascend gradually after CPB.The values of WBC and cTnI begin to ascend after CPB at that time, achieve the peak after CPB 24 hour, then descend. They have distinct positive correlations (P<0.01) with other examination items. Moreover their dynamic state curves are easy to be observed. The value of MYO achieves the peak twice after CPB at that time and after CPB 24 hour. Conclusion: WBC and cTnI are the preferential monitoring items of inflammatory reaction and myocardial damage for the patients undergone CABG surgery by CPB.
关 键 词:心肌损伤标志物 冠状动脉搭桥术 体外循环 检测分析 炎性指标 肌酸激酶同工酶MB 器官功能障碍 细胞因子
分 类 号:R542.22[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.40